Introduction
Leukocyte adhesion deficiency (LAD) is an autosomal recessive primary immunodeficiency that has been reported in people 1 (LAD Type I), cattle 2 (bovine LAD or BLAD in Holstein cattle), and dogs [3] [4] [5] (canine LAD or CLAD in Irish and Red and White Setters), as well as CD18 null mice. 6 The disease is caused by mutations in the integrin b 2 subunit (ITGB2) gene resulting in a deficiency of the leukocyte integrin CD18 b-subunit, which forms a heterodimer with one of 4 different CD11 a-subunits. The CD11/CD18 leukocyte integrins are normally expressed on all leukocyte surface membranes 7 , mediate strong neutrophil adhesion, and serve as coreceptors for activation of T-lymphocyte proliferation. Clinically, individuals with LAD can develop omphalitis, juvenile periodontitis with loss of teeth, chronic and recurrent overwhelming bacterial infections poorly responsive to antibiotic therapy, and impaired pus formation and wound healing. 2, 5, [8] [9] [10] [11] [12] [13] [14] Affected animals and people rarely reach adulthood unless receiving intensive antimicrobial therapy, bone marrow transplantation 15, 16 , or gene therapy. [17] [18] [19] These individuals typically develop a severe leukocytosis with the majority being mature neutrophils. Although the clinical syndrome associated with LAD is predominately caused by deficient adhesion of neutrophils, CD18 deficiency also results in Tlymphocyte dysfunction. 6, 20 While many different mutations in the ITGB2 gene have been reported in human patients with LAD 21 , single missense mutations are responsible for BLAD (D128G) 22 and CLAD (C36S) 4, 23 which were widespread in the affected breeds due to inbreeding and popular sire effect.
Primary immunodeficiencies have rarely been reported in cats 24 with the exception of athymic nude Birman kittens 25 that suffer an absolute absence of immunoglobulins, similar to nude mice. 26 The objective of this study was to characterize the clinicopathologic, immunologic, and molecular genetic features of FLAD in a cat experiencing severe recurring bacterial infections and leukocytosis.
Materials and Methods

Animals
In this report, we studied and documented an adult cat affected by an ITGB2 gene mutation in comparison to healthy control cats (based on normal CBCs and physical exams). Blood samples (2-4 mL) were collected from the jugular vein at the Mountain View Veterinary Hospital in Vancouver, WA, USA. Samples were anticoagulated with EDTA or heparin and analyzed locally or shipped chilled overnight to the University of Pennsylvania and National Institutes of Health for further investigations. Feline blood samples left over from diagnostic tests at the laboratory were used for screening studies. These studies were approved by the institutional animal care and use committee at the University of Pennsylvania, and owner consent was obtained.
Routine diagnostic blood analyses
Routine CBC analyses were performed on EDTAanticoagulated blood samples at 2 commercial veterinary reference laboratories (Antech Diagnostics and IDEXX Laboratories, Portland, OR, USA). Quantitative serum immunoglobulin concentrations were measured at Colorado State University, Fort Collins, CO, USA.
Flow cytometry assay of CD18 expression
For immunostaining, monoclonal antibodies that cross-react with feline surface markers were used.
Heparinized blood from the affected cat and controls was subjected to RBC lysis with ammonium-chloridepotassium lysing buffer (ACK; Quality Biological, Inc., Gaithersburg, MD, USA) and washed in phosphatebuffered saline (PBS; Quality Biological) plus 1% bovine serum albumin (BSA, Fraction V; MP Biomedicals LLC, Solon, OH, USA) to isolate peripheral blood leukocytes (PBL). Cells were immunostained with an isotype control mouse IgG1 antibody (Dako, Carpinteria, CA, USA), mouse anti-human CD14 monoclonal antibody (T € UK4; Dako), and/or mouse anti-canine CD18 monoclonal antibody (CA1.4E9; AbDSerotec, Raleigh, NC, USA) as per the manufacturer's recommendations. Neutrophil populations were determined based on size (forward scatter), granularity (side scatter), and negative CD14 staining. Approximately 1 9 10 5 cells were evaluated by flow cytometry (Becton Dickinson FACSCalibur, San Jose, CA, USA) and analyzed using Cellquest (Becton Dickinson) and FlowJo (Tree Star, San Carlos, CA, USA) software programs.
Cell adhesion assay
Leukocyte adhesion was assessed with aliquots of PBL suspensions (preparation described above) using fibrinogen as the substrate for CD11/CD18-mediated binding. 18, 27 Fibrinogen (50 lL; plasminogen-depleted human plasma; Calbiochem/EMD Biosciences, La Jolla, CA, USA) at 2 mg/mL in PBS was used to coat thin-bottom 96-well microtiter plates (Costar 3720; Corning Inc., Corning, NY, USA) for 16 h at 4°C. For blocking experiments, PBL were preincubated with 2 lg of mouse anti-human CD18 monoclonal antibody 60.3 (cross-reactive with feline CD18) per 1 million cells. 28 Nucleated cells were counted after labeling with a DNA-specific fluorescent dye (Hoechst 33342; Invitrogen, Carlsbad, CA, USA). Triplicates of 1 9 10 5 cells in 100 lL from proband and control PBL were activated by 100 ng/mL phorbol 12-myristate 13-acetate (PMA; SigmaAldrich, St. Louis, MO, USA), an activator of CD11/ CD18 epitope up-regulation, and incubated at 37°C for 20 min in the fibrinogen-coated microtiter plates. Negative controls were incubated without PMA. Nonadherent cells were removed by washing with a manual microplate washer (EL401 BioTek Instruments, Inc., Winooski, VT, USA) using PBS with 1% BSA. Wells were fixed using PBS with 1% BSA and 1% formaldehyde, and 5 lg/mL Hoechst 33342 dye. Adherent cells were counted by an iCys Research Imaging Cytometer (CompuCyte Corporation, Cambridge, MA, USA).
T-cell proliferation assay
Lymphocyte-enriched mononuclear cells were isolated by gradient separation from heparinized blood in Nycoprep 1.077A (Axis-Shield PoC AS, Dundee, UK) tubes centrifuged at 800g for 30 min at 20°C. After washing twice in PBS with 0.1% human albumin (Grifols Therapeutics, Inc., Research Triangle Park, NC, USA), cells were incubated with 1 lM fluorescent cell staining dye carboxyfluorescein diacetate succinimidyl ester (CFSE) using the CellTrace CFSE Cell Proliferation Kit (Invitrogen). Duplicates of 4 9 10 5 cells were added to each well of a round bottom 96-well plate containing either 0, 1, or 100 pg/mL of staphylococcal enterotoxin A (SEA; Sigma, St. Louis, MO, USA) and cultured for 7 days. Cells were harvested and labeled with an AlexaFluor 647-conjugated monoclonal anticanine CD18 antibody CA1.4E9 (AbDSerotec) and analyzed by flow cytometry for CD18 expression (FL4 channel) and CFSE staining (FL1 channel; BD FACSCalibur; Becton-Dickinson).
Reverse Transcription-PCR amplification of feline ITGB2 RNA Aliquots of EDTA blood samples were mixed with RNALater (Ambion, Foster City, CA, USA) for storage. Subsequently, blood cells were washed in PBS, and RNA was purified (PureLink RNA Mini Kit; Invitrogen) as per the manufacturer's instructions. Purified RNA (43.5 ng from proband, 12 ng from a healthy control cat) was subjected to reverse transcription-PCR (RT-PCR) using a SuperScript III One-Step RT-PCR System with Platinum Taq DNA Polymerase (ThermoFisher Scientific, Waltham, MA, USA). The RNA was reverse transcribed at 50°C for 30 min, and the cDNA was amplified using 10 pmol primer sets 1-7 (for primer sequences see Table S1 ) with initial denaturation at 94°C for 2 min, 40 cycles at 94°C for 15 s, 55°C for 30 s, 68°C for 60 s, and a final extension of 5 min at 68°C. The PCR products were electrophoresed on 1.2% Seakem LE agarose gels (Lonza, Walkersville, MD, USA), and bands were individually excised, purified (QIAquick Gel Extraction Kit; Qiagen, Valencia, CA, USA), and sequenced by Sanger sequencing (CCR Genomics Core of the National Cancer Institute, Bethesda, MD, USA).
PCR amplification of exons 2 and 3 of feline ITGB2 genomic DNA Genomic DNA was isolated from EDTA blood (Wizard Genomic DNA Purification Kit; Promega Corp, Madison, WI, USA). Approximately 250 ng of genomic DNA was subjected to PCR amplification using 10 pmol of primer sets 8 and 9 to exons 2 and 3, respectively (Table S1) , with an initial denaturation at 95°C for 1 min, 35 cycles at 95°C for 15 s, 56°C for 15 s, 72°C for 45 s, and a final extension at 72°C for 3 min. The PCR products were purified and sequenced as described above. The cDNA and genomic sequences were analyzed using MacVector software (Apex, NC, USA).
Screening for a mutant allele in a cat population
A PCR-based assay was used to distinguish between the mutant and normal exon 2 alleles using primer set 8 (Table S1 ), followed by routine amplification and agarose gel separation for the identification of affected, carrier, and normal cats. Whole EDTA blood samples left over after diagnostic testing from 93 cats of various breeds (53 Domestic Shorthair, 19 Domestic Longhair, and 21 unknown) were screened among cats living within approximately 25 miles of the proband around Vancouver, WA, USA.
Results
Case description
The affected cat was a neutered male Domestic Longhair cat having reached 7 years of age despite a lifelong history of health issues, thanks to excellent husbandry and medical management. At 2 months of age the kitten was first presented to the primary care clinician at the Mountain View Veterinary Hospital in Vancouver, WA, USA, because of severe gingivitis and periodontitis. By 9 months of age, all permanent teeth had been lost or had to be extracted ( Figure 1A ). Recurrent lip ulcerations occurred between the age of 3 and 7 years ( Figure 1B ), and were treated with long-term antimicrobial therapy and intermittent analgesics and glucocorticosteroids. In addition, the affected cat also experienced severe recurring upper respiratory infections, gastroenteritis, anterior uveitis, subcutaneous abscesses, and epidermal sloughing/cellulitis with sepsis secondary to small grooming lacerations that were managed at the primary care clinic. The cat was kept indoors, isolated from other cats, and the fur was regularly clipped short. Body temperature ranged from 38 to 40°C when the cat was being evaluated and treated for infections, and CBCs showed severe neutrophilia (Table 1) , accompanied by mild left shifts during severe clinical episodes. A multitude of bacterial species were cultured over the years, but the cat was feline leukemia virus antigen and feline immunodeficiency virus antibody negative on repeat testing.
These clinical features were suggestive of a primary immunodeficiency which was studied from December 2009 through June 2011 when the cat was 5.5-7 years of age. During the last months of life, the cat developed progressive cardiomegaly, severe hepatomegaly, gastric wall thickening, and chronic upper respiratory infections. The cat was euthanized at age 7, after experiencing a grand mal seizure that left the cat unable to ambulate. A necropsy was not performed.
Routine laboratory data
The cat had a persistent leukocytosis due to a mature neutrophilia that was of greater magnitude during clinical episodes of apparent infection and inflammation (Table 1) 
Leukocyte studies
Flow cytometry
Because recurrent and persistent bacterial infections and severe mature leukocytosis are hallmarks of LAD, the cat's leukocytes were evaluated for CD18 expression. While leukocytes from a control cat showed strong CD18 expression as assessed with anti-CD18 antibody by flow cytometry, there was no expression of CD18 on the leukocytes of the proband (Figure 2) , indicating a complete CD18 deficiency. 
Leukocyte adhesion assay
To determine how the lack of CD18 expression affected leukocyte function, leukocytes from the proband were examined for their ability to adhere. Unstimulated control feline leukocytes adhered very loosely to the fibrinogen (a CD11/CD18 ligand)-coated wells. Upon stimulation with PMA (an activator of CD11/CD18), adhesion of normal leukocytes to the fibrinogencoated well was increased 8-fold (Figure 3 ). This adherence of activated normal feline leukocytes to fibrinogen was blocked by preincubation with the anti-CD18 antibody 60.3, demonstrating CD18 specificity of the adhesion function. In contrast, the proband's leukocytes failed to adhere even under PMA stimulation, indicating a severe CD18-dependent adhesion defect ( Figure 3 ).
T-cell proliferation assay
As cells from LAD-affected individuals typically have impaired T-cell responses, a T-cell proliferation assay was performed. T lymphocytes from a control cat exhibited only a mild basal proliferation but showed a dose-dependent increase in response to SEA, a CD18-dependent antigen (Figure 4 ). In contrast, T lymphocytes from the proband showed only a weak response at the low (1 pg/mL) SEA concentration, but a comparable response to the control cat at the high SEA (100 pg/mL) concentration, suggesting a CD18-independent T-cell response at higher SEA concentrations.
Analyses of feline ITGB2 cDNA and genomic DNA A strategy was developed to sequence the feline ITGB2 cDNA using 7 primer pair sets spanning nearly the entire ITGB2 coding region, from exon 2 to 16 (Table S1) . Like other species, the translational ATG start codon of the feline ITGB2 resides in exon 2. Although the ITGB2 coding region from a control cat was successfully sequenced using this strategy, primer set 1, covering base pairs (bp) 11 (in exon 2) to 596 (in exon 6), failed to amplify a product from the proband's RNA with RT-PCR. Because primer set 2 used in the RT-PCR reaction covering exons 5-9 yielded the expected product size for both the control cat and proband, a mutation in exons 1-4 of ITGB2 was suspected in the proband. Further analysis of ITGB2 cDNA sequences from the control cat from exons 1-16 yielded 6 polymorphisms between its ITGB2 cDNA sequence (GenBank accession number MF374490) (Table S2 ) and the published feline mRNA sequence (GenBank accession number XM_011285804.2), including one amino acid change, while the others were silent single nucleotide polymorphisms. The Y106H amino acid change is predicted to be a neutral change by PROVEAN prediction software. 29 In contrast, the ITGB2 cDNA sequence from the affected cat was identical from exons 5 through 16 to the published cat cDNA sequence.
To ascertain the proband's ITGB2 mutation, primer sets 8 and 9 were designed to specifically amplify the region of exons 2 and 3 from genomic DNA. Indeed, the PCR amplicons of the genomic DNA of the exon 2-3 region indicated a size difference between the proband and control cat ( Figure 5A ). Subsequent DNA sequencing revealed a 24 bp deletion at the exon 2 to intron 2 boundary region involving the donor splice site (c.46_58 + 11del) ( Figure 5B) .
To determine the consequences of the observed genomic deletion of the normal exon 2 donor splice site on the proband's ITGB2 RNA, a PCR primer set from exon 1 to 5 was designed. While a single cDNA fragment of the expected size was amplified by RT-PCR from a control cat, 2 smaller fragments were identified in the affected cat's cDNA on gel electrophoresis (Figure 6A) , due to direct splicing of exon 1 of the proband's ITGB2 to exon 3, and a minor splice product to exon 4 ( Figure 6B ). In contrast, only the normally spliced exon 1 to exon 2 fragment of ITGB2 was seen in Figure 3 . Comparison of in vitro adhesion by activated peripheral blood leukocytes from a cat affected by feline leukocyte adhesion deficiency and a control cat. Purified leukocytes from the proband and control cat were bound to fibrinogen in the absence (no PMA) or presence of the CD11/CD18 activator phorbol 12-myristate 13-acetate (PMA). Adhesion of activated leukocytes was completely blocked by anti-CD18 antibody 60.3 in the control cat, demonstrating CD18 specificity. The vertical lines indicate the SD of triplicate data. the control cat. As exon 2 contains the standard ATG start codon for CD18, an aberrant splice product to exon 3 or 4 eliminates the use of this ATG codon, such that the next available ATG start codon does not occur until exon 4 (Figures 7 and S1 ). However, this potential ATG start codon is in a different reading frame than the prototypical ITGB2 ATG start codon, and termination would occur 4 codons downstream leading to premature translational termination and rapid destabilization of the mRNA.
Screening for the mutant ITGB2 allele among cats
To determine the prevalence of the c.46_58 + 11del mutation in the local cat population, 93 cats from the geographic region where the proband was living were screened for the ITGB2 deletion by exon 2 genomic PCR. However, only the normal allele was found, and thus no carrier or affected cats were identified.
Discussion
Our investigations demonstrate a severe leukocyte adhesion dysfunction in a cat caused by a deleterious mutation in the ITGB2 gene coding for the b2-chain of the leukocyte integrin CD18. Thus, this is the first report of a feline leukocyte adhesion deficiency referred to here as FLAD. While the disease manifestations were comparable to LAD observed in children (type I), Holstein calves, and Setter puppies, the FLAD phenotype appeared milder, potentially due to an alternative, CD18-independent T-cell activation pathway.
2,9,13,30 Figure 4 . Lymphocyte proliferation assay as measured by cytoplasmic CFSE dye loss in T lymphocytes from a cat affected by feline leukocyte adhesion deficiency and a control cat. Stimulation of T cells from the affected cat with the superantigen SEA (concentrations indicated) resulted in a lower proliferation rate compared to a control cat at 1 pg/mL, but at 100 pg/mL, CD18-independent proliferation comparable to the control's T lymphocytes was observed. The percentage of proliferating CD18À and CD18+ cells is indicated in the lower left and right hand quadrants (Y-axis), respectively, by CFSE loss.
Indeed, the progressive juvenile gingivitis and periodontitis leading to the early loss of dentition and the ascending umbilical infections seen in the affected cat reported here are also the early clinical hallmarks of LAD in other species. 10, 13, 31 Similarly, the recurring upper respiratory infections, gastroenteritis, anterior uveitis, subcutaneous abscesses, and epidermal sloughing/cellulites with sepsis are signs of a systemic hereditary immunodeficiency. Deficient pus formation despite severe neutrophilia is characteristic for LAD as the neutrophils are unable to egress from blood vessels, migrate to the site of infection, and mount an effective innate immune response.
The affected cat was kept indoors and isolated from other animals yet still experienced a variety of bacterial infections. The observed poor response to antibiotics and recurrence of clinical disease upon withdrawal of antibiotics in this cat are typical of a hereditary leukocyte defect. However, this cat with FLAD had a protracted course of disease over 7 years, while individuals of other species with LAD succumb to infections before adulthood unless receiving intensive medical care and/or bone marrow transplantation and gene therapy. 15, 16 The medical management and nursing care provided to the cat reported here likely contributed to a longer life span of the proband. Interestingly, our lymphocyte proliferation data suggest a CD18-independent T-cell activation pathway bridging the immune defect in cats (see below). Similarly, the first Irish setter diagnosed with LAD lived to 4 years of age with intense nursing and medical care for the various bacterial infections 5 , and a few calves were kept alive up to 3 years of age with extensive medical care and husbandry. 8 The key hematologic feature of LAD in any reported species is persistent severe leukocytosis, which may vary with antibiotic therapy and diseasefree or -controlled periods 7 that was also seen in the cat reported here. The leukocytosis is the result of an increased myeloid cell proliferation in the bone marrow in response to inflammatory mediators and the concurrent inability of the granulocytes to egress from blood vessels in patients with LAD. It is noteworthy that in contrast to the typically left-shifted neutrophilia of acute infections, there was a mature neutrophilia with occasional hypersegmentation, indicating complete and orderly maturation of granulocytes and possibly longer residing time in bone marrow and peripheral blood circulation of the reported cat and LAD patients of other species. 2, 13 Although the mature neutrophilia usually predominates in any LAD patient, extreme monocytosis and lymphocytosis due to the lack of functional b 2 -integrins can also be present.
As long as cross-reacting antibodies are available that bind to the common b 2 -chain, a diagnosis of LAD can be readily made by flow cytometry in any species, as was the case here with an anti-canine CD18 antibody cross-reacting with the feline CD18. 5, 9, 22 Anti-CD11 antibodies against the different a-chain partners of the leukocyte b 2 -integrin (CD11a-d/CD18 heterodimers) were not tested in this case, as binding in the absence of the common b 2 -chain would not be expected. Patients with severe LAD will typically show no b 2 -integrin expression on any leukocytes, as demonstrated in the cat reported here. Similarly, leukocyte adhesion assays can be used to show the impaired functional adhesion defect, both at baseline and after PMA activation. Strikingly, only a minimal number of cells from the proband adhered to a fibrinogen-coated surface despite severe leukocytosis, another hallmark of LAD in the previously reported species. 2, 5, 9, 14 Because the leukocyte integrins are known to play a costimulatory role in T-cell proliferation 32 , patients with LAD may also show deficient T-lymphocyte proliferation. While the affected cat's lymphocytes were minimally reactive to incubation with a low concentration of SEA, the response was near normal at a high SEA concentration. This suggests a possible CD18-independent T-cell activation mechanism in response to SEA that is unlike LAD in other species. 17, 33 It is possible that this alternative T-cell stimulation in this cat enabled the longer survival. While the clinical course of this FLAD cat might have suggested a less extensive ITGB2 mutation, the complete lack of any CD18 expression on it's leukocytes indicated a major error in b 2 -integrin synthesis. Indeed, genomic and cDNA analyses of the exonic and adjacent intronic regions of the ITGB2 gene sequences revealed a 24 bp deletion at the exon 2 to intron 2 boundary and a frameshift, resulting in a truncated, likely nonexpressed gene product due to premature translational termination and mRNA destabilization and decay 34 , although no protein expression studies A model of normal integrin b 2 (ITGB2) RNA splicing in the control cat is compared to the proposed aberrant splicings in a cat affected by feline leukocyte adhesion deficiency. In the proband most aberrant splicing occurred from exon 1 to 3 (solid line) with a minority of abnormal splicing from exon 1 to 4 (dotted line) instead of exon 1 to 2. The frameshift resulting in the ATG start codon in exon 4 in the aberrant RNA from the proband is shown along with the early termination TGA stop codon.
were performed in this current case. Similar aberrant RNA splicing has also been observed in severely affected human cases with LAD type I. [35] [36] [37] The 24 bp deletion in the ITGB2 gene was convenient for developing a screening PCR assay, as the mutant and normal alleles can be readily discerned by the PCR product size difference on a gel. A limited survey involving almost 100 cats from the proband's geographic region revealed no heterozygous (carrier) or homozygous mutant (affected) cats suggesting that this mutant allele may be rare in the feline population.
At this time FLAD seems to be a rare immunodeficiency in cats with the ITGB2 mutation being isolated and not widespread. In contrast, the mutant alleles in Holstein cattle 22 and Red and White Setters 4,38 were relatively common with worldwide occurrence, and screening programs have successfully reduced the occurrence of BLAD and CLAD.
In conclusion, this naturally occurring FLAD exhibits features similar to LAD in other species, albeit the clinical course may be milder based upon this report. While FLAD is rare and BLAD and CLAD have been controlled and nearly eliminated in Holstein cattle and Setters, clinicians and clinical pathologists should be aware of this devastating immunodeficiency and the options to reach a precise diagnosis by flow cytometry and/or DNA testing.
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